Status:
NOT_YET_RECRUITING
Comparison of Outcomes of Right Internal Jugular Port Implantation in Patients With Right Versus Left Breast Cancer Undergoing Chemotherapy
Lead Sponsor:
Golestan University of Medical sciences
Conditions:
Port-A-Cath
Eligibility:
All Genders
Brief Summary
Chemotherapy is an essential component of breast cancer treatment. Frequent intravenous injections may lead to phlebitis and limited venous access, therefore implantable venous ports are increasingly ...
Detailed Description
Breast cancer is the most common malignancy among women worldwide. Chemotherapy remains a cornerstone of treatment, whether in neoadjuvant or adjuvant settings. Despite advancements in drug formulatio...
Eligibility Criteria
Inclusion
- Female patients with breast cancer (right or left side)
- Underwent chemotherapy port implantation via right internal jugular vein between 2017-2024 in Gorgan medical centers
Exclusion
- Prior neck surgery or radiotherapy involving right jugular area
- Incomplete medical records
Key Trial Info
Start Date :
November 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT07197320
Start Date
November 1 2025
End Date
March 1 2026
Last Update
September 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
5Th Azar Medical Center
Gorgan, Outside of the US, Iran, 4917956808